Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Genetic marker rs12558842 strongly linked to male hair loss.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Two gene areas linked to male pattern baldness found, more research needed.

Reversing female hair loss.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Hormones and genes affect hair growth and male baldness.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

New genes found linked to balding, may help develop future treatments.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Genomic approach finds new possible treatments for hair loss.

Various treatments exist for hair loss, but more research is needed for better options.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

New genes linked to male pattern baldness were found on chromosome 20p11.